Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
Biomaterials|October 30, 2009
Surfaces modified with nanometer-thick silver-impregnated polymeric films that kill bacteria but support growth of mammalian cellsAnkit Agarwal, Tahlia L Weis, Michael J Schurr, et al.Blood|July 2, 2009
Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesionWilliam A Anong, Taina Franco, Haiyan Chu, et al.Physical Review Letters|May 16, 2007
Energy splitting of the ground-state doublet in the nucleus 229ThB R Beck, J A Becker, P Beiersdorfer, et al.Investigational New Drugs|December 22, 2015
Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulinLee-Chuan C Yeh, Asok Banerjee, Veena Prasad, et al.Nucleic Acids Research|December 14, 2011
Structural and functional analysis of the archaeal endonuclease Nob1Thomas Veith, Roman Martin, Jan P Wurm, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|April 15, 2025
Optical coherence tomography reveals retinal structural abnormalities in α-synucleinopathies: insights from the Padua-CESNE cohortM Campagnolo, M Puthenparampil, A Emmi, et al.Proceedings of the National Academy of Sciences of the United States of America|September 5, 2013
Essential ribosome assembly factor Fap7 regulates a hierarchy of RNA-protein interactions during small ribosomal subunit biogenesisUte A Hellmich, Benjamin L Weis, Anatoli Lioutikov, et al.The Journal of Biological Chemistry|January 5, 2008
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblastsJeong-Ah Kang, Ying Zhou, Tahlia L Weis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2017
FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic MelanomaMeredith K Chuk, Jennie T Chang, Marc R Theoret, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2017
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on IpilimumabMaitreyee Hazarika, Meredith K Chuk, Marc R Theoret, et al.Pageof 12